Sign in

CIK 0001907108

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
854012572
Phone
+1 212-547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-18 Adler Eric Chief Medical Officer Sale −615 $9.27 $6K 72,646
2025-10-17 Adler Eric Chief Medical Officer Sale −3,344 $8.94 $30K 73,299
2025-10-17 Adler Eric Chief Medical Officer Sale −38 $9.56 $363 73,261
2025-10-15 Adler Eric Chief Medical Officer Grant or award +9,570 76,643
2025-08-18 Adler Eric Chief Medical Officer Sale −608 $4.67 $3K 67,073
2025-05-16 Adler Eric Chief Medical Officer Sale −585 $2.77 $2K 67,681
2025-02-19 Adler Eric Chief Medical Officer Sale −2,359 $4.41 $10K 68,266
2025-01-07 Adler Eric Chief Medical Officer Grant or award +43,750 70,625
2025-01-07 Adler Eric Chief Medical Officer Grant or award · Stock Option (right to buy) +87,500 87,500
2024-02-02 Adler Eric Chief Medical Officer Grant or award +26,875 26,875
2024-02-02 Adler Eric Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +161,250 161,250

Page 1 of 1 · 11 trades